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HIV-1 integrase (IN) is an essential enzyme for  viral replication and a validated target for the 
development of drugs against AIDS [1,2]. Several IN inhibitors were identified through in vitro 
inhibition assays with recombinant IN and among them the  β-diketo acid class of compounds 
showed the most promising results. After about 15 years of study, one compound (Raltegravir, 
MK-0518), a diketo acid-based derivative, has been approved in therapy [3]. It is believed that the 
β-diketo acid pharmacophoric motif could be involved in a functional sequestration of one or both 
divalent metal ions, which are critical cofactors at the enzyme catalytic site.
In  a  previous  work  [4]  we reported  results  about  the  coordination  ability  of  the  diketo  acid 
pharmacophore, and discussed on the anti-HIV-1 IN activity of a series of synthesized  β-diketo 
acid metal complexes. We demonstrated that the diketo acid functionality chelates divalent metal 
ions  in  solution  giving  complexes  with  metals  in  different  stoichiometric  ratios.  We  also 
postulated  that  the  diketo  acids  act  as  complexes  in  their  active  form,  and the  difference  in 
activities is related to the complexes they preferentially form in solution.  
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Herein, a further extension of this study is reported. In particular, a new set of complexes with 
different  stoichiometry  was  synthesized,  and  a  series  of  potentiometric  measurements  were 
conducted for two diketo acids as model ligands in the presence of other divalent metal ions in 
order  to  outline  a  speciation  model.  The  first  X-ray  solved  structure  of  a  diketo  acid  metal 
complex is presented. 
Moreover, we tested the obtained complexes for anti-HIV 1 IN activity.  Furthermore, detailed 
docking studies were conducted in order to investigate the mode of binding of the free ligands 
compared with their metal complexes on the active site.
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